PDS Biotechnology Corp Investing Cash Flow
PDS Biotechnology Corp (PDSB) reported Investing Cash Flow of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-30
- PDS Biotechnology Corp net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was -$1.00.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for fiscal 2024 was -$29.00K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- PDS Biotechnology Corp net cash provided by (used in) investing activities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.00 derived: sum of 2 quarters · filed 2026-03-30 | -$29.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$29.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$29.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 10-K · filed 2025-03-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | $0.00 derived: sum of 3 quarters · filed 2021-03-18 | $0.00 10-K · filed 2021-03-18 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | $275.00K derived: sum of 4 quarters · filed 2021-03-18 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $275.00K derived: sum of 3 quarters · filed 2021-03-18 | $275.00K derived: sum of 4 quarters · filed 2021-03-18 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-13 | $275.00K derived: sum of 2 quarters · filed 2021-03-18 | $275.00K derived: sum of 3 quarters · filed 2021-03-18 | $275.00K derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $275.00K derived: sum of 2 quarters · filed 2021-03-18 | $275.00K derived: sum of 3 quarters · filed 2021-03-18 | $29.38M 10-K · filed 2021-03-18 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $29.11M 10-Q · filed 2020-11-13 | $29.11M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $29.11M 10-Q · filed 2020-08-13 | $29.11M derived: sum of 3 quarters · filed 2020-08-13 | $29.11M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $29.11M 10-Q · filed 2020-05-13 | $29.11M derived: sum of 2 quarters · filed 2020-05-13 | $29.11M derived: sum of 3 quarters · filed 2020-05-13 | $29.11M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-03-27 | $0.00 derived: sum of 3 quarters · filed 2020-03-27 | $0.00 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | -$27.97K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | -$27.97K derived: sum of 3 quarters · filed 2019-08-01 | -$83.06K derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | -$27.97K derived: sum of 2 quarters · filed 2019-05-14 | -$83.06K derived: sum of 3 quarters · filed 2019-05-14 | -$99.44K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$27.97K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$83.06K derived: sum of 2 quarters · filed 2019-02-21 | -$99.44K derived: sum of 3 quarters · filed 2019-02-21 | -$188.72K 10-K · filed 2019-02-21 |
| 2017-09-30 | -$55.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$71.47K derived: sum of 2 quarters · filed 2018-11-01 | -$160.75K 10-Q · filed 2018-11-01 | -$508.05K derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | -$16.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$105.66K 10-Q · filed 2018-08-01 | -$452.96K derived: sum of 3 quarters · filed 2018-08-01 | -$597.05K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | -$89.28K 10-Q · filed 2018-05-01 | -$436.58K derived: sum of 2 quarters · filed 2018-05-01 | -$580.67K derived: sum of 3 quarters · filed 2018-05-01 | |
| 2016-12-31 | -$347.30K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$491.39K derived: sum of 2 quarters · filed 2018-03-01 | -$686.71K 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$144.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$339.41K 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | -$195.32K 10-Q · filed 2017-08-01 | |||
| 2015-12-31 | -$1.31M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |